{"id":"https://openalex.org/W3203907320","doi":"https://doi.org/10.1186/s40360-021-00527-5","title":"Spontaneous recovery from sunitinib-induced disruption of sarcomere in human iPSC-cardiomyocytes and possible involvement of the Hippo pathway","display_name":"Spontaneous recovery from sunitinib-induced disruption of sarcomere in human iPSC-cardiomyocytes and possible involvement of the Hippo pathway","publication_year":2021,"publication_date":"2021-10-06","ids":{"openalex":"https://openalex.org/W3203907320","doi":"https://doi.org/10.1186/s40360-021-00527-5","mag":"3203907320","pmid":"https://pubmed.ncbi.nlm.nih.gov/34610839","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8493690"},"language":"en","primary_location":{"id":"doi:10.1186/s40360-021-00527-5","doi":"https://doi.org/10.1186/s40360-021-00527-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40360-021-00527-5","pdf_url":"https://bmcpharmacoltoxicol.biomedcentral.com/track/pdf/10.1186/s40360-021-00527-5","source":{"id":"https://openalex.org/S29101735","display_name":"BMC Pharmacology and Toxicology","issn_l":"2050-6511","issn":["2050-6511"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Pharmacology and Toxicology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmcpharmacoltoxicol.biomedcentral.com/track/pdf/10.1186/s40360-021-00527-5","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025366458","display_name":"Toshikatsu Matsui","orcid":"https://orcid.org/0000-0002-8394-2866","observed_orcids":["https://orcid.org/0000-0002-8394-2866"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshikatsu Matsui","raw_affiliation_strings":["Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006017684","display_name":"Tadahiro Shinozawa","orcid":"https://orcid.org/0000-0001-6402-3824","observed_orcids":["https://orcid.org/0000-0001-6402-3824"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Tadahiro Shinozawa","raw_affiliation_strings":["Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan. tadahiro.shinozawa@takeda.com","Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan. tadahiro.shinozawa@takeda.com","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5006017684"],"corresponding_institution_ids":["https://openalex.org/I44892455"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":0.3494,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.55998478,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"22","issue":"1","first_page":"55","last_page":"55"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.8955000042915344,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.8955000042915344,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10505","display_name":"Pluripotent Stem Cells Research","score":0.017799999564886093,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12065","display_name":"Hippo pathway signaling and YAP/TAZ","score":0.016100000590085983,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.8460000157356262},{"id":"https://openalex.org/keywords/drug-induced-cardiotoxicity","display_name":"drug-induced cardiotoxicity","score":0.8619999885559082},{"id":"https://openalex.org/keywords/sarcomere-disruption","display_name":"sarcomere disruption","score":0.9710000157356262},{"id":"https://openalex.org/keywords/induced-pluripotent-stem-cell-derived-cardiomyocytes","display_name":"iPSC-derived cardiomyocytes","score":0.9490000009536743},{"id":"https://openalex.org/keywords/hippo-signaling-pathway","display_name":"Hippo signaling pathway","score":0.9330000281333923},{"id":"https://openalex.org/keywords/yap","display_name":"YAP","score":0.8519999980926514},{"id":"https://openalex.org/keywords/xmu-mp-1","display_name":"XMU-MP-1","score":0.8709999918937683},{"id":"https://openalex.org/keywords/spontaneous-recovery","display_name":"spontaneous recovery","score":0.7009999752044678},{"id":"https://openalex.org/keywords/drug-washout","display_name":"drug washout","score":0.7699999809265137},{"id":"https://openalex.org/keywords/cardiac-recovery","display_name":"cardiac function recovery","score":0.367000013589859}],"concepts":[{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.9415056109428406},{"id":"https://openalex.org/C68731436","wikidata":"https://www.wikidata.org/wiki/Q1337087","display_name":"Sarcomere","level":3,"score":0.8047260642051697},{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.77916419506073},{"id":"https://openalex.org/C107459253","wikidata":"https://www.wikidata.org/wiki/Q674925","display_name":"Induced pluripotent stem cell","level":4,"score":0.5873311758041382},{"id":"https://openalex.org/C172512520","wikidata":"https://www.wikidata.org/wiki/Q5768379","display_name":"Hippo signaling pathway","level":3,"score":0.47372356057167053},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43641093373298645},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34742382168769836},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3466380834579468},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34428003430366516},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3427191376686096},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.27931395173072815},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2092646062374115},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.17940035462379456},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1790718138217926},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.1687765121459961},{"id":"https://openalex.org/C207200792","wikidata":"https://www.wikidata.org/wiki/Q428914","display_name":"Myocyte","level":2,"score":0.12468290328979492},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07603725790977478},{"id":"https://openalex.org/C145103041","wikidata":"https://www.wikidata.org/wiki/Q1151519","display_name":"Embryonic stem cell","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077210","descriptor_name":"Sunitinib","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000090683","descriptor_name":"Hippo Signaling Pathway","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D000091102","descriptor_name":"YAP-Signaling Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000096926","descriptor_name":"Benzenesulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012518","descriptor_name":"Sarcomeres","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D032383","descriptor_name":"Myocytes, Cardiac","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D032383","descriptor_name":"Myocytes, Cardiac","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D057026","descriptor_name":"Induced Pluripotent Stem Cells","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1186/s40360-021-00527-5","doi":"https://doi.org/10.1186/s40360-021-00527-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40360-021-00527-5","pdf_url":"https://bmcpharmacoltoxicol.biomedcentral.com/track/pdf/10.1186/s40360-021-00527-5","source":{"id":"https://openalex.org/S29101735","display_name":"BMC Pharmacology and Toxicology","issn_l":"2050-6511","issn":["2050-6511"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Pharmacology and Toxicology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:7386324","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC8493690","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:34610839","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34610839","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC pharmacology & toxicology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8493690","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8493690/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Pharmacol Toxicol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:ea41605f85dd419fa7386d2580f109af","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/ea41605f85dd419fa7386d2580f109af","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Pharmacology and Toxicology, Vol 22, Iss 1, Pp 1-10 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s40360-021-00527-5","doi":"https://doi.org/10.1186/s40360-021-00527-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40360-021-00527-5","pdf_url":"https://bmcpharmacoltoxicol.biomedcentral.com/track/pdf/10.1186/s40360-021-00527-5","source":{"id":"https://openalex.org/S29101735","display_name":"BMC Pharmacology and Toxicology","issn_l":"2050-6511","issn":["2050-6511"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Pharmacology and Toxicology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3203907320.pdf","grobid_xml":"https://content.openalex.org/works/W3203907320.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1998028009","https://openalex.org/W2028160054","https://openalex.org/W2036903182","https://openalex.org/W2059487482","https://openalex.org/W2099359513","https://openalex.org/W2111813732","https://openalex.org/W2116137381","https://openalex.org/W2129149076","https://openalex.org/W2133359909","https://openalex.org/W2136575072","https://openalex.org/W2164802689","https://openalex.org/W2166535515","https://openalex.org/W2512544075","https://openalex.org/W2730289288","https://openalex.org/W2780401357","https://openalex.org/W2886893896","https://openalex.org/W2888679886","https://openalex.org/W2892387525","https://openalex.org/W2938891495","https://openalex.org/W2963554762","https://openalex.org/W2974604172","https://openalex.org/W2979184884"],"related_works":["https://openalex.org/W2924348384","https://openalex.org/W1963699880","https://openalex.org/W4411670041","https://openalex.org/W179777829","https://openalex.org/W2727082838","https://openalex.org/W4237569474","https://openalex.org/W4394869481","https://openalex.org/W7221196488","https://openalex.org/W2625212592","https://openalex.org/W2941384598"],"abstract_inverted_index":{"BACKGROUND:":[0],"Sunitinib":[1],"is":[2,71],"known":[3],"to":[4,60,72,90,222,224,253,284],"cause":[5,39],"cardiotoxicity":[6,63,98],"in":[7,24,43,64,81,87,137,185,188,266],"clinical":[8,82],"settings.":[9],"However,":[10],"among":[11],"sunitinib-treated":[12],"patients":[13],"experiencing":[14],"adverse":[15,295],"cardiac":[16,19,79,186,296],"events,":[17],"decreased":[18],"function":[20],"was":[21,156,214],"reportedly":[22],"reversible":[23],">":[25],"50%":[26],"of":[27,54,68,77,116,133,144,147,169,205,209,212,232,242,269,272,278,293],"the":[28,52,75,92,101,114,131,134,138,142,170,239,251,260,267,279,291],"patients.":[29],"We":[30,180],"previously":[31],"showed":[32],"that":[33,190,248],"anti-cancer":[34],"drugs":[35],"such":[36],"as":[37],"sunitinib":[38,109,127,163,195,218,235],"marked":[40],"sarcomere":[41,55,117,140,175,257,273],"disruption":[42,56,241,271],"human":[44],"induced":[45],"pluripotent":[46],"stem":[47],"cell-derived":[48],"cardiomyocytes":[49],"(iPSC-CMs),":[50],"and":[51,89,113,125,164,174,220,236,259,274],"extent":[53,143,208],"can":[57,84],"be":[58,85],"used":[59],"predict":[61],"drug-induced":[62],"humans.":[65],"The":[66,207],"aim":[67],"this":[69],"study":[70],"investigate":[73],"whether":[74],"reversibility":[76],"sunitinib-induced":[78,97,139,240,256,270,294],"events":[80],"settings":[83],"mimicked":[86],"vitro,":[88],"examine":[91,130],"molecular":[93],"mechanism":[94],"responsible":[95],"for":[96,110,289],"focusing":[99],"on":[100],"Hippo":[102,135,153,171,261,280],"pathway.":[103],"METHODS:":[104],"iPSC-CMs":[105,158,189,249],"were":[106,119,159,177,191],"stimulated":[107,161],"with":[108,162,234],"72":[111,199],"h":[112,200,203],"morphology":[115],"structures":[118,176],"analyzed":[120],"by":[121,194],"high-content":[122],"analysis":[123],"before":[124],"after":[126,197,217,227],"washout.":[128,229],"To":[129],"involvement":[132],"pathway":[136,262,281],"disruption,":[141,258],"nuclear":[145,210],"localization":[146,211],"YAP1":[148,213],"(yes-associated":[149],"protein":[150],"1,":[151],"a":[152,165,182,198,264,286],"signaling":[154],"target)":[155],"determined.":[157],"also":[160],"small":[166],"molecule":[167],"inhibitor":[168],"pathway,":[172],"XMU-MP-1":[173,237],"analyzed.":[178],"RESULTS:":[179],"observed":[181],"spontaneous":[183],"recovery":[184],"sarcomeres":[187],"significantly":[192,215],"disrupted":[193],"treatment":[196],"or":[201],"144":[202],"washout":[204],"sunitinib.":[206],"reduced":[216],"stimulation":[219,231],"tended":[221],"return":[223],"normal":[225],"levels":[226],"drug":[228],"Simultaneous":[230],"iPSC-CM":[233],"suppressed":[238],"sarcomeres.":[243],"CONCLUSIONS:":[244],"These":[245],"results":[246],"indicate":[247],"have":[250],"ability":[252],"recover":[254],"from":[255],"plays":[263],"role":[265],"process":[268],"its":[275],"recovery.":[276],"Inhibition":[277],"may":[282],"help":[283],"develop":[285],"co-medication":[287],"strategy":[288],"mitigating":[290],"risk":[292],"events.":[297]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-10-11T00:00:00"}